Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 111,297,177
- Total 13F value
- $366,220,521
- Share change
- +26,528,528
- Put/Call ratio
- 31%
- SEC-reported price per share
- $3.29
- Number of holders
- 165
- Value change
- +$89,540,533
- Number of buys
- 84
- Number of sells
- 62
- Shares outstanding
- 353,007,843
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
165
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
William H. Miller III
Disclosed value leader
William H. Miller III
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 9.2%
13D/G row: William H. Miller III
Showing 1-6 of 15 holder rows.
Quick read
William H. Miller III leads the comparable SEC ownership view at 9.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens William H. Miller III's linked filing trail.
Comparable ownership
Top 5
William H. Miller III
9.2%
Patient Capital Management, LLC
4.6%
ADAGE CAPITAL PARTNERS GP, L.L.C.
3.2%
BlackRock, Inc.
3.2%
VANGUARD GROUP INC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| William H. Miller III |
13D/G
William H. Miller III Living Trust dated April 17, 2017
|
9.2%
|
$154,936,259
34,051,925 shares
|
$0 | 26 Jun 2025 |
| Patient Capital Management, LLC |
13F
Company
|
4.6%
|
$23,101,613
16,268,741 shares
|
— | 30 Jun 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3.2%
|
$16,011,920
11,276,000 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
3.2%
|
$15,826,611
11,145,501 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.6%
|
$12,879,441
9,070,029 shares
|
— | 30 Jun 2025 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
1.2%
|
$6,075,700
4,278,662 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
165
Shares
111,297,177
Rows available
165
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
146
Q3 2025 holders
165
Holder diff
19
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend